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Clear Cell Renal Cell Carcinoma: Deep Learning-Based Prediction of Tumor Grade from 
Contrast-Enhanced CT 
Qing Dai 
 
Abstract 
Tumor grading is an important prognostic parameter for renal cell carcinoma (RCC). 
However, current grading schemes require an invasive surgical procedure, putting patients at 
risks including increased risk of hemorrhage, infection, renal failure, or death. Furthermore, low 
grade RCC is indolent with low mortality risk and may not require treatment. Therefore, a pre-
operative and non-invasive assessment of malignancy grade may be beneficial and facilitate 
optimal timing of treatment. In recent years, deep learning-based image analysis has gained wide 
popularity in cancer prognosis and prediction. The goal of this study is to investigate the 
feasibility and performance of a deep-learning-based model for clear cell RCC grading 
prediction from contrast-enhance computed tomography (CECT). After institutional review 
board approval, an institutional pathology database was queried for all renal biopsies between 
December 2002 and October 2018.  All included patients received a CT with a non-contrast and 
at least one post-contrast series. All patients have Fuhrman grade confirmation from surgical 
pathology. Tumors were manually annotated by a radiologist on either the corticomedullary or 
nephrographic phase CECT. Rectangular regions of interest (ROI) were drawn on each slice 
throughout the tumor and used as inputs to the Deep CNN ResNet50. A low grade or high grade 
label was assigned to each patient. Sensitivity, specificity, accuracy, and AUC were calculated 
based on a five-fold cross-validation. Preliminary results from a small subset of data successfully 
predicted 67% of high-grade clear cell RCCs, and 94% of the low-grade clear cell RCCs. 
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1. Introduction:  
Renal cancer is the sixth and eighth most common cancer type in men and women respectively in 
United States with more than 73,800 new cases every year (American Cancer Society). Renal 
cell carcinoma (RCC), accounts for 90% of renal cancers.  Since 1975, the incidence rate of renal 
cancer doubled from 7.1 per 100,000 to 15.5 per 100,000, while the mortality remained constant 
(National Cancer Institute). Part of this rise is likely due to the use and development of newer 
imaging techniques, including computed tomography (CT), magnetic resonance imaging (MRI) 
and ultrasonography (US) (Sasaguri and Takahashi; Vedanayagam et al.; Herts et al.; Dunlop 
and Cohen). Given that kidneys are positioned deep within the body and cannot be palpated on a 
physical exam, renal tumors often have no signs or symptoms at an early stage. Most of the renal 
cancers are actually found incidentally from imaging tests for a different clinical indication 
(Herts et al., 2018; Sasaguri & Takahashi, 2018; Vedanayagam, Bhattacharya, & Sriprasad, 
2017).  
Tumor grading is an important prognostic parameter for renal cancers. Low grade indicates that 
cancer cells are growing slowly, while high grade indicates that the cancer cells are growing 
quickly and are more likely to spread. The most popular grading scheme for renal cancers is 
called Fuhrman grading (Fuhrman et al.), which is based on three nuclear morphological 
parameters of the pathological materials: nuclear size, nuclear shape, and nucleolar prominence 
(Table 1). Examples of different grades are shown in Figure 1. The Fuhrman grading system has 
been validated to demonstrate strong prognostic value. However, pathological tumor grading 
requires an invasive surgical procedure, which is associated with risk of hemorrhage, infection, 
renal failure, or death. Given that benign renal tumors and many small RCCs demonstrate slow 
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growth and low metastatic potentials, a pre-operative assessment of tumor grade could risk 
stratify patients before surgery. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1, Examples of different Fuhrman grading. Grade 1-4, A-D.  
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Table 1. Fuhrman grading criteria. 
 
 
Diagnostic medical imaging is the standard of care for pre-operative tumor 
characterization and staging and CT scan is the preferred imaging modality to evaluate renal 
masses.  CT scan measures the average X-ray attenuation coefficient of a tissue voxel, and the 
attenuation coefficient is then translated and normalized to Hounsfield Units (HU) from the 
following equation:  
𝐻𝑈 = 1000 × 
𝜇 − 𝜇𝑤𝑎𝑡𝑒𝑟
𝜇𝑤𝑎𝑡𝑒𝑟 − 𝜇𝑎𝑖𝑟
 
where 𝜇, 𝜇𝑤𝑎𝑡𝑒𝑟  and 𝜇𝑎𝑖𝑟 are the attenuation coefficients of a tissue voxel, water and air. The CT 
pixel value is display on a scale from -1024 to +3071 in HU units. Water and air are 0 are -1000 
in HU scale. For renal masses characterization, a homogenous lesion with >70 HU is usually 
considered as a hemorrhagic cyst, and a lesion with < -20 HU is usually considered as a benign 
tumor subtype or a proteinaceous cyst.  
 Contrast-enhanced CT (CECT) is most commonly used for RCC detection and 
characterization. The purpose of CECT is to better visualize the lesions by enhancing their 
 Nuclear size Nuclear Shape Nucleoli 
Grade 1 Small (approximately 
10P)m Round and uniform Absent or inconspicuous 
Grade2 Larger (approximately 
15P)m 
 
Slightly irregular in 
outlines 
Frequently visible at 
high power (400X) 
Grade 3 Even larger nuclei 
(approximately 20P) 
 
Obvious irregular 
outlines 
Prominent and large at 
low power (100X) 
Grade 4 Similar to grade 3 
 
Extremely irregular 
outlines, bizarre and 
multilobed shapes 
Conspicuous nucleoli 
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contrast from the healthy surrounding tissues (Figure 2). After intravenous injection of a contrast 
agent, the lesion has different enhancement characteristics at different phases, so the timing of 
postcontrast CT acquisition is important (Table 2). For clear cell RCC, the high vascular 
structure often exhibits a strong enhancement in the late-arterial phase. If the lesion is small, the 
mass may be more conspicuous in portal venous phase, which also has a strong enhancement 
(Dyer et al.).  
 
 
 
 
 
Table 2: Contrast-enhanced CT Acquisition Protocol. This is 
the standard protocol for renal masses at our institution. 
 
 
 
Figure 2 Contrast enhancement. This figure shows a four-phase CECT scan of a patient 
with a single renal mass in the right kidney.  
 
  
Contrast-enhanced  
CT 
Time (second) 
Pre-contrast 0 sec, during expiration 
Late Arterial  40 sec, during expiration 
Portal venous 80 sec, during expiration 
Delayed >100 sec, during expiration 
Pre-contrast Arterial Delayed Portal Venous 
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Machine learning is widely used for developing automate medical imaging workflows. 
Conventional machine learning (ML) techniques aim to select and extract hand-crafted features 
from imaging data. This method has been applied to many investigations, such to predict renal 
tumor subtypes and malignancy (Sasaguri and Takahashi; Yu et al.; Huhdanpaa et al.; Ding et 
al.). However, the performance of conventional ML models relies heavily on the quality of those 
hand-crafted features to be extracted and is not reliable due to the variance among different 
datasets. In recent years, deep neural networks have shown promising results in every field of 
medical imaging   (Havaei et al.; Zhang et al.; Zhou et al.; Coy et al.; Han et al.). Compare to 
conventional ML models, deep neural network models act as a generic feature extractor, learning 
directly from input not from human experts.  
Two approaches are commonly used to train a deep neural network: train from scratch 
and transfer learning. Train from scratch is a method where all the parameters of a model are 
randomly initialized and are fully optimized to a specific dataset. However, the performance of 
training a model from scratch may be constrained by over-fitting (model fitted too close to a 
limited dataset) and data imbalance (a disproportionate ratio between class observations). 
Medical imaging data is inherently suffered from both of these two problems. Transfer learning 
is a method where a model developed and optimized for a task is reused on a second task. With 
transfer learning, a pre-trained model is used as a starting point followed by fine tuning using the 
desired dataset. Tajbakhsh et al. showed that fine-tuned deep neural networks outperformed fully 
trained models when limited data were available (Tajbakhsh et al.).  
The goal of this study is to investigate the feasibility and performance of a deep neural 
network-based clear cell RCC grading prediction model from CECT. A preliminary study using 
a small dataset is reported here.  
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2. Methods 
2.1 Subjects 
After institutional review board approval, we searched for patients with biopsy proven 
RCC were identified from radiology, pathology and clinical databases. A summary of patient 
selection criteria is shown in Figure 3. Only patient with stage 1 cancers were included for this 
study. Patients with obvious local invasion to neighboring tissues or distant metastases were 
excluded from this study. Patients with obvious metastases were also excluded. All patients 
obtained CECT with at least one pre-contrast acquisition scan and one contrast-enhanced 
acquisition. Surgical pathology results were available for all tumors from image-guided 
percutaneous biopsies, partial nephrectomy or radical nephrectomy. A unique histological grade 
was assigned to each histologic material based on Fuhrman grading system. Patients with surgery 
performed prior to baseline imaging scans were excluded. 
 
2.2 CECT Data Acquisition: 
Our institutional Renal Mass Protocol is described as follows: Helical CT scans were 
obtained with a gantry rotation speed of 0.5 rotations/second, table speed at 39.37mm/rot, tube 
voltage of 120 kVp, min/max tube current of 150/570 mA, and beam pitch of 0.984:1. The scan 
was first acquired at slice thickness of 1.25mm, then reformatted automatically in axial (2.5mm), 
sagittal (5mm) and coronal (3mm) planes and sent to a picture archiving and communication 
system (PACS). Reformatted images had sizes of 512x512 with pixel spacing of 0.9765mm. 
Following pre-contrast scans, 150cc non-ionic contrast agents (Omnipaque 350) was 
administrated through IV injection at 5ml/s followed by a 50-cc saline flush.  
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Figure 3 Patient selection profile. 
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2.3 Image Annotation  
All CECT exams were automatically retrieved from PACS in DICOM format in a 1996 
Health Insurance Portability and Accountability Act (HIPAA) compliant manner. Tumor ROIs 
were labeled on MD.ai (New York, New York, United States), a cloud-based collaborative 
annotation platform that allows the storage, viewing and annotation of anonymized medical 
images. Tumor ROIs were drawn manually using a polygon tool on the late arterial or portal-
venous phase axial images depending on where the tumor was more conspicuous. XY 
coordinates of the vertices of the polygons were saved and exported as a .json file.  
 
2.4 Image Pre-preprocessing and Data Preparation 
The DICOM images were in HU unit and ranged from -1024 to 3071 with a soft tissue 
window (window center 40, window width 400). Based on the vertices, square bounding boxes 
with size 128x128 were automatically generated with tumor centroid in the center. Image was 
then cropped from 512x512 to 128x128. Random left-right flips is applied to augment the 
datasets to increase the diversity of the datasets for model training.  
Transfer learning was used in this study. For the used by a pre-trained neural network, 
two additional image processing were performed: First the images were converted from 
grayscale images to 3-channel images by duplication and concatenation. Second, the image were 
resized from 128x128 to 224x224, because the height and the width were expected to be at least 
224x224. Final input dimensions for model training were 224x224x3. A five-fold cross-
validation was applied with an 80/20 split at the patient level. All slices were shuffled at the 
beginning of each training/validation split.  
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Image annotation and processing steps are illustrated in Figure 4. Image processing was 
performed using Pydicom 1.3.0 and pynrrd 0.4.0, respectively. Image transformation and 
augmentation were performed using Dataset class and transforms.functional module provided in 
Pytorch v1.1.0 .   
 
 
Figure 4 The image processing pipeline. Original CECT datasets were retrieved from PACS in 
DICOM format. Late arterial or portal venous phase were selected based on series instance UID 
stored in DICOM headers. Annotation was performed using a polygon tool. A 128x128 
bounding box was generated and cropped. Annotation was performed on MD.ai. Image 
processing was performed in python 3.6.  
 
 
2.5 Deep Residual Network 
A residual neural network (ResNet) architecture was used for model training (He et al.). 
First introduced in 2015, the core idea of ResNet is to add “shortcut connections” between layers 
within a residual block. Instead of simply stacking layers and learning from the outputs of the 
previous layers, residual blocks (as shown in Figure 5) allow the model to skip certain layers and 
directly learn an identity function X by setting the residual ℱ(𝑥, {𝑊𝑖}) to zero in the following 
equation: 
                                    𝑦 =  ℱ(𝑥, {𝑊𝑖}) + 𝑥                                                     (2) 
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where  𝑥 is the input of this residual block, 𝑊𝑖 is the weights to be updated in this residual block, 
and 𝑦 is the output of this residual block. Adding residual blocks minimizes the gradient vanishing 
problem, giving us the ability to train a deeper network.   
  Figure 5 Residual Block. (He et al.) 
 
2.6 Implementation 
Given the limited data available for training, we used transfer learning to train our 
classification model. In this study, a ResNet 50 model was pre-trained on ImageNet datasets, 
which contains over 1 million images from 1000 classes (Russakovsky et al.). Only the last two 
residual layers were trained, and the first two residual layers were frozen with fixed parameters. 
The final layer was a classifier that performed a binary classification: 0 for low grade (Fuhrman 
grade 1 or 2) and 1 for high grade (Fuhrman grade 3 or 4). Adaptive Momentum (Adam) 
optimization was used for parameter updating (Kingma and Ba). Learning rate was set to 1e-5, 
learning rate momentum = 0.8, weight decay = 0.8. A weighted cross-entropy loss was used with 
a weight = 2.5. The model was developed in Pytorch v1.1.0 and trained on NVIDIA Titan X 
Pascal GPU with 12GB memory. 
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2.7 STATISTICAL ANALYSIS 
Since our model performs a binary classification, we define the following term:  
• True positives (TP) are cases where the model predicted high grades (label 1), and 
they do have high grades (label 1); 
• False positives (FP) are cases where model predicted high grades (label 1), but 
they are low grades (label 0); 
• False negatives (FN) are cases where model predicted low grade (label 0), but 
they are high grades (label 1); 
• True negatives (TN) are cases where model predicted low grades (label 0), and 
they are low grades (label 0).  
We used confusion matrices to visualize the above terms (Figure 6).  
Figure 6. Confusion matrix. 
 
Sensitivity, specificity and accuracy are comparison metrics commonly used in medical 
tests. Sensitivity measures how well the test identifies those with positive conditions, specificity 
measure how well the test identifies those with negative conditions, and accuracy measures how 
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well the test identifies both negative and positive conditions. Sensitivity, specificity and accuracy 
can be calculated from the following equations:  
                                    𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 =  
𝑇𝑃
𝑇𝑃+𝐹𝑁.
                                               (3) 
                                   𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 =  
𝑇𝑁
𝑇𝑁+𝐹𝑃
              (4)  
                                   𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =  
𝑇𝑃+𝑇𝑁
𝑇𝑃+𝑇𝑁+𝐹𝑃+𝐹𝑁
       (5) 
A receiving operating characteristic (ROC) curve measures how good a binary 
classification model can distinguish two classes. A ROC curve plots sensitivity vs 1-specificity at 
different classification thresholds. Area under the curve (AUC) also measures how the 
performance of the model distinguishes the positives and the negatives. A perfect classifier has 
AUC of 1, while a random classifier has AUC of 0.5. (Figure 7) 
Figure 7. Examples of receiving operating characteristic (ROC) curves and area 
under the curve (AUC). 
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3 Results 
Out of 895 patients with renal tumors, 505 patients with 528 lesions were diagnosed as 
clear cell RCCs. These proportions (56.4% of all tumors, 73.7% of all RCCs) were close to the 
numbers reported in previous studies (Figure 8) (Davenport et al.). Among all patients with clear 
cell RCCs, 50 were grade 1, 311 were grade 2, 120 were grade 3, and 24 were grade 4. 361 
(71.5%) patients were categorized to low grade (grade 1 or 2) and 144 (28.5%) were categorized 
to high grade (grade 3 or 4). Table 3 showed the characteristics of the entire cohort.  
Table 4 showed a subset of the complete population that were analyzed in this 
preliminary study. Annotation were performed on 40 patients with 40 clear cell RCCs, 26 with 
high grade clear cell RCC tumors and 14 with low grade clear cell RCC tumors. The mean size 
of the lesions was 4.10 cm (standard deviation, 1.52cm; range, 1.1 – 6.7 cm).  
Table 5 summarized the performances of our deep residual networks. We explored the 
impact of 3 different batch sizes to the performance. The total number of trainable parameters 
was approximately 11 million. The best performing model achieved 0.67 for sensitivity, 0.94 for 
specificity, 0.84 for accuracy, 0.0.88 for AUC. Confusion matrices and receiver operating 
characteristics (ROC) curves were shown in Figure 9 and Figure 10.  
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Figure 8 Renal Tumor Subtypes. Among all 895 patients identified with 
renal tumor, 514 (58%) had clear cell RCCs, 109 (12%) had oncocytoma, 99 
(11%) had papillary RCC, 48 (5%) had chromophobe RCC, 33 (4%) had 
angiomyolipoma, 92 (10%) had mixed type tumor or tumor type 
unclassified. 
  
58%
12%
11%
5%
4%
10%
Tumor Subtypes
Clear Cell RCC
Oncocytoma
Papillary RCC
Chromophobe RCC
Angiomyolipoma
Others
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Table 3 Cohort characteristics. the cohort comprises contains 505 patients with 528 clear cell 
RCCs. Note each tumor is counted separately if bilateral tumors or multiple tumors are 
presented.  
  
 Low Grade, N = 361 High Grade, N = 144 Total, N = 505 
Contrast phase    
Non-contrast 361 (100%) 143 (99.3%) 504 (99.8%) 
Late arterial 169 (46.8%) 53 (36.8%) 222 (43.0%) 
Portal venous 319 (88.4%) 128 (88.9%) 447 (88.5%) 
Delayed 229 (63.4%) 89 (61.8%) 318 (63.0%) 
Procedure type    
Biopsy 61 (16.9%) 14 (9.7%) 75 (14.8%) 
Partial Nephrectomy 199 (55.1%) 77 (53.5%) 276 (54.7%) 
Radical Nephrectomy 101 (28.0%) 53 (36.8%) 154 (30.5%) 
Laterality    
Left 182(50.4%) 76 (52.8%) 258 (51.1%) 
Right 170 (47.1%) 66 (45.8%) 236 (46.7%) 
Bilateral 9 (2.5%) 2 (1.4%) 11 (2.2%) 
Size    
Mean, Std (cm) 3.80 r 1.57 4.66 r 1.59 4.04 r 1.62 
Range (cm) 1 - 7 1.7 – 7 1 - 7 
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 Table 4 Characteristics of a preliminary subset, containing 40 patients with 40 clear cell RCCs. 
 
 Low Grade, N = 24 High Grade, N = 16 Total, N = 40 
Procedure type    
Biopsy 6 (25%) 2 (12.5%) 6 (15%) 
Partial Nephrectomy 16 (33.7%) 8 (50%) 24 (0.6%) 
Radical Nephrectomy 4 (16.7%) 6 (37.5%) 10 (25%) 
Laterality    
Left 10 (41.7%) 9 (52.8%) 19 (47.5%) 
Right 16 (66.7%) 4 (45.8%) 20 (50%) 
Bilateral 0 (0%) 1(1.4%) 1 (2.5%) 
Size    
Mean, Std (cm) 3.83 r 1.48 4.41 r 1.71 4.04 r 1.57 
Range (cm) 1.1 – 6.3 1.8 - 6.7 1.1 – 6.7 
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Table 5 Performance of the models. Batch size with 16 reached the best sensitivity, 
specificity and accuracy  
  
 
Figure 9 Confusion matrices. Results for batch size of 4, 16, and 64 are shown. True positives 
are shown at the top-left corner, false negatives at top-right corner, false positives at bottom-
left corner, and true negatives at bottom-right corner.  
  
 Sensitivity Specificity Accuracy 
Batch Size = 4 0.55 0.88 0.77 
Batch Size = 16 0.67 0.94 0.84 
Batch Size = 64 0.53 0.81 0.71 
a.  b.  
c.  
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Figure 10 Receiving Operating Characteristics. Areas under the curve are shown in the 
legends. Batch size of 16 reached the best AUC value, which is consistent with Table 4.   
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4 Discussion 
We presented a deep learning-based framework for pre-operative pathological grade 
prediction of clear cell RCC from CECT imaging. Our model successfully predicted 67% of 
high-grade clear cell RCCs, and 94% of the low-grade clear cell RCCs.  
As far as we know, no previous study has used deep neural network to discriminate low 
and high Fuhrman grading. Several works used conventional machine learning for this task: Ding 
et al. used six non-texture features (diameters, absolute and relative enhancement, etc.) and four 
texture features (out of 184 texture features) from CECT imaging, and a logistic regression 
model was used for prediction (Ding et al.); Bektas et al. used additional texture features, such as 
gradient features, image nonuniformities, wavelet features, etc., and more classifiers were 
investigated (Bektas et al.). Both studies proved CECT provided enough predictive information 
for RCC classification and grading. However, both studies required hand-crafted feature 
selection schemes which lacked generalizability.  
The use of deep learning on RCC classification has been validated on CECT dataset for 
similar tasks: Coy et al. used a pre-trained Google Inception model to differentiate between clear 
cell RCC and its benign mimics (Coy et al.). Han et al. also used a pre-trained Google Inception 
model to distinguish three major subtypes of RCCs on three-phase CECT images (Han et al.).   
The generalization of this study is subject to several considerations. First is data scarcity. 
The patient selection criteria of this study were narrow, and the number of patients included in 
this preliminary study was small (N = 40). We addressed this by augmenting our training 
datasets, as well as ensuring that class proportion of our training datasets was similar to the 
complete cohort and populations in other studies. We didn’t balance the data because we wanted 
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the model to see an accurate representation of the class proportion in reality. Also, the clinical 
characteristics of these 40 patients was similar to the full datasets.  
Second is bias. The ground truth provided by pathology for training may be biased from 
sampling errors or from pathology readers. Further, the annotation provided by our radiologist 
may similarly be inaccurate due to reader bias and variability. We can recruit more readers to 
perform annotation and measure inter-reader variability in further investigation. 
Some future directions of this study include: The full 895 patient dataset (12 times more) 
will be used for model development as soon as it is annotated; alternative networks will be 
explored, such as Google Inception or 3D networks. 
In conclusion, the work presented here demonstrated a deep learning-based model was 
useful to capture the difference between low- and high-grade clear cell RCCs. Given the 
important clinical implication of a pre-operative pathological grade prediction, this could lead to 
a paradigm shift in the management of renal cancers in the future with improved optimization of 
the timing of interventions. 
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